Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Weak Hands

<< Previous

Bullboard Posts

Next >>

Comment by StockingUp21on Apr 12, 2021 1:35pm

117 Views

Post# 32978246

RE:Weak Hands

Why only retail investors when talking about institutional investors for years!!

Arbourmark wrote: Currently Antibe is held by many retail investors who have very short term view. We are just shaking out weak hands here, these are retail investors who look out often by days or weeks. If they don't see immediate increase in sp they sell and move on to the next penny flip.

Many of the people currently selling most likely invested based on hearing big news in 30 days like uplisting to Nasdaq or new partnership etc. They have not seen any SP appreciation and are moving on to other opportunities. These people are happy with 10-30% returns in short time frames.

Those who possess the patience to hold Antibe and let management complete their game plan will be rewarded with huge SP increase.

My suggestion is stop looking at SP multiple times per day, you will drive yourself crazy. If you believe in the science, if you believe in management and their advisors, just relax and let them do their job. Trust me they don't read these boards nor are they concerned about SP, they have knowledge we don't and they have a process and plan to execute on.